Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
naloxone (narcan) (1 trial)
oxycodone (oxycontin) (1 trial)
fesoterodine (toviaz) (1 trial)
Autonomic Dysreflexia (Phase 2)
Chronic Pain (Phase 3)
Spinal Cord Injuries (Phase 3)
Trials (2 total)
Trial APIs (3 total)